The DOI matches its Crossref record.
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.
Open accessAbstract
CTL are held to be an important host defense mechanism in persistent herpes-virus infections. We have therefore studied the nature and specificity of human cytomegalovirus (HCMV)-specific CTL in normal persistently infected individuals. This was achieved by using vaccinia recombinants encoding viral genes expressed at different stages of the virus replicative cycle, a structural glycoprotein gB (vac.gB) and the major 72-kD immediate early nonstructural protein (vac.IE) of HCMV, combined with limiting dilution analysis of the CTL response. In two subjects, 43 and 58% of HCMV CTL precursors (CTLp) lysed vac.IE-infected cells, in contrast to less than 6% lysing gB-infected cells. HCMV-specific CTL could also be generated by secondary in vitro stimulation with vac.gB- but not vac.IE-infected autologous fibroblasts. The high frequency of 72-kD IE protein-specific CTL suggests that this is at least a major recognition element for the HCMV-specific CTL response in asymptomatic persistently infected individuals, and CTL with this specificity may be important in maintaining the normal virus/host equilibrium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Sylwester, A. W., Mitchell, B. L., Edgar, J. B., Taormina, C., Pelte, C., Ruchti, F., Sleath, P. R., Grabstein, K. H., Hosken, N. A., Kern, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050882 · Cited by 1,339
Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B., & Sissons, J. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7569-7579.1996 · Cited by 688
Self-citationReusser, P., Riddell, Sr., Meyers, J., & Greenberg, P. (1991) · Blood · doi:10.1182/blood.v78.5.1373.1373 · Cited by 666
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O’Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., & Callan, M. F. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1827 · Cited by 499
T cell responses to cytomegalovirus
Klenerman, P., & Oxenius, A. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.38 · Cited by 483
Latency and reactivation of human cytomegalovirus
Sinclair, J., & Sissons, P. (2006) · Journal of General Virology · doi:10.1099/vir.0.81891-0 · Cited by 425
Self-citationCarmichael, A., Jin, X., Sissons, P., & Borysiewicz, L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.249 · Cited by 418
Self-citationBunde, T., Kirchner, A., Hoffmeister, B., Habedank, D., Hetzer, R., Cherepnev, G., Proesch, S., Reinke, P., Volk, H.-D., Lehmkuhl, H., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042384 · Cited by 364
Steven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G., & Rickinson, A. B. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1605 · Cited by 350
McLaughlin‐Taylor, E., Pande, H., Forman, S. J., Tanamachi, B., Li, C., Zaia, J. A., Greenberg, P. D., & Riddell, S. R. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890430119 · Cited by 342
A Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter
Hengel, H., Koopmann, J.-O., Flohr, T., Muranyi, W., Goulmy, E., Hämmerling, G. J., Koszinowski, U. H., & Momburg, F. (1997) · Immunity · doi:10.1016/s1074-7613(00)80350-7 · Cited by 315
Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M., & Khanna, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5226-5240.2003 · Cited by 308
Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance
Reddehase, M. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri932 · Cited by 291
Lehner, P. J., Karttunen, J. T., Wilkinson, G. W. G., & Cresswell, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6904 · Cited by 283
T-cell epitope mapping by flow cytometry
Kern, F., Surel, I. P., Brock, C., Freistedt, B., Radtke, H., Scheffold, A., Blasczyk, R., Reinke, P., Schneider-Mergener, J., Radbruch, A., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-975 · Cited by 278
Gratama, J. W., van Esser, J. W. J., Lamers, C. H. J., Tournay, C., Löwenberg, B., Bolhuis, R. L. H., & Cornelissen, J. J. (2001) · Blood · doi:10.1182/blood.v98.5.1358 · Cited by 278
Kern, F., Surel, I. P., Faulhaber, N., Frömmel, C., Schneider-Mergener, J., Schönemann, C., Reinke, P., & Volk, H.-D. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8179-8184.1999 · Cited by 277
Kern, F., Bunde, T., Faulhaber, N., Kiecker, F., Khatamzas, E., Rudawski, I., Pruss, A., Gratama, J., Volkmer‐Engert, R., Ewert, R., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340637 · Cited by 277
Human cytomegalovirus immunity and immune evasion
Jackson, S. E., Mason, G. M., & Wills, M. R. (2011) · Virus Research · doi:10.1016/j.virusres.2010.10.031 · Cited by 262
John, S., Yuzhakov, O., Woods, A., Deterling, J., Hassett, K., Shaw, C. A., & Ciaramella, G. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.029 · Cited by 229
Metadata
- Authors
- Borysiewicz, L. K., Hickling, J. K., Graham, S., Sinclair, J., Cranage, M. P., Smith, G. L., & Sissons, J. G.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1988-09-01
- Volume
- 168
- Issue
- 3
- Pages
- 919-931
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2039635018
- Cited by
- 246
- References
- 0
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.